If you need more lookups,
subscriptions start at $34 USD/month.
Beth Giblin Location
New York, NY, US
Beth Giblin Work
VP, Head of Medical Affairs @ (October 2026 - Present)
VP, Head of Field Medical Affairs @ (April 2025 - October 2026)
VP, Head of US Medical Affairs @ (November 2022 - February 2025)
Vice President- US Medical Affairs - Oncology and Hematology @ EVERSANA (BioLineRx) (November 2022 - June 2024)
Director, Scientific and Medical Affairs @ (March 2021 - November 2022)
National Director - Medical Affairs - Oncology Solid Tumor @ (March 2021 - November 2022)
COVID-19 LTC Immunization Pharmacist @ (December 2020 - June 2021)
RWJ Foundation @ (November 2019 - December 2020)
Regional Associate Director Oncology MSLs @ (January 2005 - September 2011)
Associate Director US Medical Strategy @ (June 2003 - June 2005)
Manager Phase IV Clinical Trials @ (March 2001 - June 2003)
Postdoctoral Fellowship @ (July 2000 - March 2001)
Beth Giblin Education
University of Rhode Island
PharmD
APhA Immunization Course
Activities and societies: APhA Immunization Course
Beth Giblin Skills
Advisory Boards
Clinical Development
Clinical Trials
Cross-functional Team Leadership
Field Medical Management
Independent Medical Education Grants
Investigator Initiated Studies
KOL Management
Medical Affairs
Medical Communications
Medical Information Systems
Medical Review
Medical Strategy
Oncology Clinical Research
Presentation Skills
Training
Beth Giblin Summary
Beth Giblin, based in New York, NY, US, is currently a VP, Head of Medical Affairs at Belite Bio. Beth Giblin brings experience from previous roles at Precigen, BioLineRx, EVERSANA (BioLineRx) and MacroGenics, Inc.. Beth Giblin holds a PharmD @ University of Rhode Island. With a robust skill set that includes Advisory Boards, Clinical Development, Clinical Trials, Cross-functional Team Leadership, Field Medical Management and more. Beth Giblin has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Beth Giblin?
Find contact details for 700 million professionals.